The diffusion of generics after patent expiry in Germany
Year of publication: |
November 2016
|
---|---|
Authors: | Blankart, Katharina ; Stargardt, Tom |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 17.2016, 8, p. 1027-1040
|
Subject: | Pharmaceutical industry | Market regulation | Off-patent markets | Product life cycle | Generic entry | Generic market share | Deutschland | Germany | Pharmaindustrie | Generika | Generic drugs | Patent | Produktlebenszyklus | Marktanteil | Market share | Arzneimittel | Pharmaceuticals | Arzneimittelmarkt | Pharmaceutical market | Markteintritt | Market entry | Innovationsdiffusion | Innovation diffusion | Regulierung | Regulation |
-
Optimal patent policy for pharmaceutical industry
Izhak, Olena, (2020)
-
Evaluating the US pharmaceutical patent policy
Izhak, Olena, (2021)
-
Newton's first law as applied to pharmacies : why entry order matters for generics
Shajarizadeh, Ali, (2015)
- More ...
-
The impact of physician-level drug budgets on prescribing behavior
Blankart, Katharina, (2018)
-
Blankart, Katharina, (2020)
-
The Effects of Off-Label Drug Use on Disability and Medical Expenditure
Blankart, Katharina, (2022)
- More ...